|
|
Article: ChemGenex Pharmaceuticals: Announcement Pursuant To Nasdaq Marketplace Rule 4350(b).
- Article from:
- Business Wire
- Article date:
- January 5, 2007
CopyrightCOPYRIGHT 2007 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
MELBOURNE, Australia & MENLO PARK, Calif. -- ChemGenex Pharmaceuticals (ASX: CXS, NASDAQ: CXSP), a pharmaceutical development company dedicated to improving the lives of patients by developing therapeutics in the areas of oncology, diabetes and obesity, today announced that its financial statements for the year ended June 30, 2006, contained in its Annual Report on Form 20-F for the year ended June 30, 2006, as filed with the Securities and Exchange Commission on December 28, 2006, included an audit report containing a going concern qualification from its independent public accounting firm.
This announcement is being made in compliance with Nasdaq Marketplace ...